Results 111 to 120 of about 11,960 (207)

Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial-0

, 2011
Copyright information:Taken from "Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial"PLoS Clinical Trials 2007;2(5):-.Published online 18 May 2007PMCID:PMC1876597. © 2007 Kamya et al.
Moses R Kamya (18018), Myers Lugemwa (74818), John B Rwakimari (74819), Sarah G Staedke (18026), Fred Wabwire-Mangen (18024), Hasifa Bukirwa (18016), Ambrose O Talisuna (51375), Bryan Greenhouse (74820), François Nosten (17237), Adoke Yeka (18017), Grant Dorsey (18025), Philip J Rosenthal (18023)   +11 more
core   +1 more source

Artemether-lumefentrine vs quinine in cerebral malaria.pdf

, 2016
Quinine by exploring its effectiveness in cerebral malaria in hospitalized patients. Materials and Methods: A randomized prospective study was conducted among 64 hospitalized cases of cerebral malaria.
AHMED TANJIMUL ISLAM (Tanjim Ovee) (3234204)
core   +1 more source

Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria

Therapeutics and Clinical Risk Management, 2009
Pauline Byakika-Kibwika1,2, Mohammed Lamorde1,2, Harriet Mayanja-Kizza1, Concepta Merry1,2, Bob Colebunders3,4, Jean-Pierre Van geertruyden4,51Infectious Diseases Institute and Infectious Diseases Network for Treatment and Research in Africa (INTERACT ...
Pauline Byakika-Kibwika, Mohammed Lamorde, Harriet Mayanja-Kizza, et al   +3 more
doaj  

Efficacy of artemether-lumefantrine for uncomplicated plasmodium falciparum malaria treatment in mozambique: a systematic review and meta-analysis. [PDF]

Malar J
Nhama A, Aide P, Torres-Fernandez D, Varo R, Nhacolo A, Bassat Q.   +5 more
europepmc   +1 more source

Therapeutic efficacy of artemether-lumefantrine and molecular markers of antimalarial drug resistance in Benin, 2022. [PDF]

Malar J
Cavros I, Kpemasse A, Maye ASY, Saliou R, Kpanou S, Houndjo W, Aissan J, Affoukou CD, Yamonmi D, Affoukou M, Zlochevska A, Deme AB, Diallo MA, Ngom B, Sene A, Sow D, Condo P, Gnanguenon V, Hassani AS, Hounto AO.   +19 more
europepmc   +1 more source

Efficacy of artemether lumefantrine vs chloroquine for the treatment of Plasmodium Vivax infection in Pakistan. [PDF]

Sci Rep
Khan S, Muqtadir J, Abbas SA, Ayoob K, Wahab A, Zaidi SHM, Das B, Bhatti S, Vohra EA.   +8 more
europepmc   +1 more source

Gaps in knowledge and use of artemether-lumefantrine among university students in Southwestern Nigeria: A cross-sectional study. [PDF]

PLoS One
Orok E, Olumoko O, Ekada I, Oladunni A.
europepmc   +1 more source

Therapeutic efficacy of artemether-lumefantrine and molecular markers of antimalarial resistance in Niger, 2022. [PDF]

Malar J
Laminou IM, Kabirou SM, Arzika II, Yahaya A, Ahmed J, Deme AB, Diallo MA, Ngom B, Gaye A, Sene A, Sow D, Coulibaly E, Bahari-Tohon Z, Sanoussi E, Koko D, Cavros I.   +15 more
europepmc   +1 more source

Therapeutic efficacy of artemether-lumefantrine plus single low dose primaquine for the treatment of uncomplicated Plasmodium falciparum malaria in a high transmission setting, Western Ethiopia. [PDF]

PLoS One
Deressa JD, Behaksra SW, Molla E, Letebo A, Shumie G, Adnew B, Alemayehu DH, Kassa FA, Seyoum T, Tafa EB, Woldekidan K, Ejigu LA, Huwe T, Keffale M, Bayissa GA, Koepfli C, Chala B, Asmamaw Y, Tadesse FG, Gadisa E.   +19 more
europepmc   +1 more source

Out of Africa: Increasing reports of artemether-lumefantrine treatment failures of uncomplicated Plasmodium falciparum infection. [PDF]

J Travel Med, 2023
Halsey ES, Plucinski MM.
europepmc   +1 more source